Kezar Life Sciences, Inc. (KZR)
NASDAQ: KZR · Real-Time Price · USD
6.22
+0.01 (0.16%)
Jan 14, 2026, 2:12 PM EST - Market open

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023
Period Ending
Dec '23
Immune-mediated Diseases and Cancer Therapeutics
7.00M

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023
Period Ending
Dec '23
United States
7.00M